Microsoft Word - MD&A Q1_2020 (Eng ) May 8, 2020 Subject : Interim Management Discussion and Analysis of Q1/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the
MD&A Q2_2020 (Eng ) July 31, 2020 Subject : Interim Management Discussion and Analysis of Q2/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
Page 1 of 4 No. RJH – SET 9/2020 10 August 2020 Subject : Management’s Discussion and Analysis for the Second Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital
: Management explanation and analysis Quarter 2/2020 ending 30 June 2020 Attention: The President of, The Stock Exchange of Thailand ZIGA Innovation Public Company Limited (“the Company”) would like to clarify
MD&A Q3_2020 (Eng ) November 2, 2020 Subject : Interim Management Discussion and Analysis of Q3/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial
: Management explanation and analysis Quarter 3/2020 ending 30 September 2020 Attention: The President of, The Stock Exchange of Thailand Ziga Innovation Public Company Limited (“the Company”) manufactures and
Page 1 of 4 No. RJH – SET 7/2020 11 May 2020 Subject : Management’s Discussion and Analysis for the First Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
THB 87.65 million as a result of collection of the receivables along with low receivable balance from decreasing in total revenue. 31-Mar 31-Dec 2020 2019 ล้านบาท % ASSETS Total Current Assets 1,507.60
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
The Stock Exchange of Thailand The Meeting of the Board of Directors of KGI Securities (Thailand) Public Company Limited (“the Company”) No. 5/2019, held on 5th November 2019, has approved the reviewed